Billy W. Loo, Jr., MD, PhD, DABR

Clinical Trials

• Recruiting Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
• Recruiting Imaging and Biomarkers of Hypoxia in Solid Tumors
• Recruiting Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
• Recruiting Molecular Analysis of Thoracic Malignancies
• Recruiting Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
• Recruiting Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
• Recruiting Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer
• Not Recruiting Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
• Not Recruiting Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
• Recruiting Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer (Cetuximab Closed as of 05/14/10)
• Recruiting Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (SABR)
• Recruiting BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
• Not Recruiting CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
• Not Recruiting High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
• Not Recruiting Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
• Not Recruiting Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer
• Not Recruiting Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
• Not Recruiting Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
• Not Recruiting Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
• Not Recruiting Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
• Not Recruiting Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
• Not Recruiting Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
• Not Recruiting Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer
• Not Recruiting The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
• Not Recruiting Radiation Therapy in Preventing CNS Metastases in Patients With Non-Small Cell Lung Cancer
• Not Recruiting Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status
• Not Recruiting Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
• Recruiting Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
• Recruiting 4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy
• Recruiting A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
• Recruiting Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers